4.950EUR-0.20%Mkt Cap: 188.81M EURP/E: —Last update: 2026-05-14
Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in …
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-12.71
PEG—
P/B-5.18
P/S8.05
EV/EBITDA-13.39
EV/Revenue8.05
EPS (TTM)-0.93
EPS (Forward)-0.39
Cash Flow & Leverage
FCF Yield4.40%
FCF Margin35.44%
Operating CF-17.43M EUR
CapEx (TTM)747.00K EUR
Net Debt/EBITDA-0.49
Net Debt6.91M EUR
Technical
SMA 504.731 (+4.6%)
SMA 2003.857 (+28.3%)
Beta0.57
S&P 52W Chg24.23%
Avg Vol (30d)186.86K
Avg Vol (10d)192.09K
Technical Indicators
RSI (14)54.9
MACD0.0574
MACD Signal0.0612
MACD Hist.-0.0038
BB Upper5.069 EUR
BB Middle4.913 EUR
BB Lower4.758 EUR
BB Width6.32%
ATR (14)0.2525 EUR
Vol Ratio (20d)0.53x
52W Range
1.19262% of range7.270
52W High7.270 EUR
52W Low1.192 EUR
Profitability
Gross Margin102.98%
EBITDA Margin-60.09%
Profit Margin-145.85%
Oper. Margin-57.75%
ROE96.92%
ROA-94.97%
Revenue Growth0.70%
Earnings Growth—
Balance Sheet
Debt/Equity-0.62
Current Ratio0.67
Quick Ratio0.65
Book Value/Sh-0.9570 EUR
Cash/Share0.5010 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.38.11M
Float30.51M
Insiders13.13%
Institutions10.79%
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)12.13 EUR
Target Range9.000 EUR – 17.00 EUR
# Analysts4
Company
Market Cap188.81M EUR
Enterprise Value188.83M EUR
Revenue (TTM)23.47M EUR
Gross Profit24.05M EUR
Net Income (TTM)-34.07M EUR
Revenue/Share0.6390 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees199
Last Price4.950 EUR
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0011049824